These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
107 related items for PubMed ID: 2463232
1. Neuropsychological correlates of urinary amine metabolites in Tourette's syndrome. Bornstein RA, Baker GB. Int J Neurosci; 1988 Sep; 42(1-2):113-20. PubMed ID: 2463232 [Abstract] [Full Text] [Related]
2. Biological markers in depression. Monoamine metabolites in urine of depressed patients and normal subjects. Vandel S, Vandel B, Bonin B, Camejo Z, Sandoz M, Allers G, Volmat R. Pharmacopsychiatry; 1985 Nov; 18(6):347-50. PubMed ID: 2418451 [Abstract] [Full Text] [Related]
3. CSF and urine biogenic amine metabolites in Rett syndrome. Lekman A, Witt-Engerström I, Holmberg B, Percy A, Svennerholm L, Hagberg B. Clin Genet; 1990 Mar; 37(3):173-8. PubMed ID: 1691058 [Abstract] [Full Text] [Related]
10. Monoamine metabolism during chronic benzodiazepine treatment and withdrawal. Petursson H, Bond PA, Smith B, Lader MH. Biol Psychiatry; 1983 Feb; 18(2):207-13. PubMed ID: 6187380 [Abstract] [Full Text] [Related]
11. Urinary MHPG and HVA excretion in boys with attention deficit disorder and hyperactivity treated with d-amphetamine. Shekim WO, Javaid J, Davis JM, Bylund DB. Biol Psychiatry; 1983 Jun; 18(6):707-14. PubMed ID: 6871304 [Abstract] [Full Text] [Related]
12. Norepinephrine and dopamine metabolites and educational variables in boys with attention deficit disorder and hyperactivity. Shekim WO, Sinclair E, Glaser R, Horwitz E, Javaid J, Bylund DB. J Child Neurol; 1987 Jan; 2(1):50-6. PubMed ID: 3624828 [Abstract] [Full Text] [Related]
13. Effects of d-amphetamine on urinary metabolites of dopamine and norepinephrine in hyperactive boys. Shekim WO, Javaid J, Dekirmenjian H, Chapel JL, Davis JM. Am J Psychiatry; 1982 Apr; 139(4):485-8. PubMed ID: 7065295 [Abstract] [Full Text] [Related]
14. Reduced excretion of MHPG in Tourette syndrome. Ang L, Borison R, Dysken M, Davis JM. Adv Neurol; 1982 Apr; 35():171-5. PubMed ID: 6959487 [No Abstract] [Full Text] [Related]
15. Obsessive-compulsive symptom clusters and urinary amine correlates in Tourette syndrome. de Groot CM, Bornstein RA, Baker GB. J Nerv Ment Dis; 1995 Apr; 183(4):224-30. PubMed ID: 7536233 [Abstract] [Full Text] [Related]
16. Urinary excretion of metabolites of norepinephrine in Tourette's syndrome. Baker GB, Bornstein RA, Douglass AB, Carroll A, King G. Mol Chem Neuropathol; 1990 Dec; 13(3):225-32. PubMed ID: 2099785 [Abstract] [Full Text] [Related]
17. Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment. Modai I, Beigel Y, Cygielman G. J Clin Psychiatry; 1986 Feb; 47(2):92-3. PubMed ID: 2418010 [Abstract] [Full Text] [Related]
18. Tourette's syndrome: clinical and neurochemical correlates. Riddle MA, Leckman JF, Anderson GM, Ort SI, Hardin MT, Stevenson J, Cohen DJ. J Am Acad Child Adolesc Psychiatry; 1988 Jul; 27(4):409-12. PubMed ID: 3182595 [No Abstract] [Full Text] [Related]